Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FKPKX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,499
Award facts
- Contract value 100% obligated
- $27,499.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27.5K delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contracting history with DLA demonstrates its capability to fulfill diverse pharmaceutical requirements through open competition, ranging from small-value transactions to orders exceeding $45K. Entresto is a cardiovascular medication commonly used in military and veteran healthcare settings, reflecting the breadth of pharmaceutical commodities the company supplies under its prime IDC agreement with DLA.
Quick answers
Who was awarded contract SPE2DB25FKPKX?
SPE2DB25FKPKX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FKPKX worth?
The government has obligated $27,499 on SPE2DB25FKPKX.
Is contract SPE2DB25FKPKX an order under another contract?
Yes. SPE2DB25FKPKX is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKPKX competed?
The extent of competition for SPE2DB25FKPKX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award